Attention Deficit/Hyperactivity Disorder (AD/HD) Characteristics and Manifestations Quiz

A common characteristic of AD/HD is excessive daydreaming, often associated with inattentiveness.

Working memory is commonly impaired in individuals with AD/HD, impacting information processing and task completion.

For a diagnosis of AD/HD in adults according to the DSM-5, symptoms must be present for at least 6 months.

Untreated AD/HD in adults may lead to an increased risk of substance abuse and occupational difficulties due to impairments in self-regulation and executive functioning.

Insomnia is a potential side effect of stimulant medications used to treat AD/HD, affecting sleep patterns.

Hyperactivity in AD/HD individuals is primarily manifested through fidgeting and restlessness.

Inattentiveness in AD/HD is characterized by forgetfulness and being easily distracted, affecting concentration.

Dopamine is often implicated in the neurobiology of AD/HD, affecting reward and motivation.

Managing AD/HD symptoms in children often involves behavioral therapy and a multimodal treatment approach encompassing various interventions.

Depression is a common comorbidity associated with AD/HD in adults, often due to struggles with executive functioning and self-regulation.

Atomoxetine is a non-stimulant medication used in the treatment of AD/HD, affecting norepinephrine levels in the brain.

The primary difference between the three subtypes of AD/HD is their symptom presentation, whether predominantly inattentive, hyperactive-impulsive, or a combination.

The subtype of AD/HD primarily associated with impulsivity is the Predominantly Hyperactive-Impulsive Presentation.

Oppositional Defiant Disorder is a common coexisting condition often seen in individuals with AD/HD.

AD/HD is most commonly diagnosed during the preschool years due to noticeable behavioral differences.

Genetics play a significant role in the development of AD/HD, with a strong genetic influence observed.

AD/HD prevalence ratio between males and females is 2:1, with males being more commonly affected.

Executive functioning is often impaired in individuals with AD/HD, affecting academic and occupational success.

The primary goal of pharmacological treatment for AD/HD is to improve executive functioning, enhancing attention, impulse control, and behavioral regulation.